- Report
- June 2025
- 90 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- January 2025
- 230 Pages
United States
From €3137EUR$3,500USD£2,691GBP
- Report
- July 2024
- 187 Pages
China
From €1613EUR$1,800USD£1,384GBP
- Report
- July 2024
- 326 Pages
China
From €3585EUR$4,000USD£3,075GBP
- Report
- July 2024
- 90 Pages
China
From €1613EUR$1,800USD£1,384GBP
- Report
- September 2023
- 114 Pages
Global
From €2644EUR$2,950USD£2,268GBP
- Report
- September 2023
- 87 Pages
Africa, Middle East
From €2644EUR$2,950USD£2,268GBP
- Report
- September 2023
- 107 Pages
Asia Pacific
From €3092EUR$3,450USD£2,653GBP
- Report
- September 2023
- 101 Pages
North America
From €2644EUR$2,950USD£2,268GBP
- Report
- September 2023
- 194 Pages
Global
From €4436EUR$4,950USD£3,806GBP
- Report
- December 2022
- 77 Pages
Global
From €4436EUR$4,950USD£3,806GBP
- Report
- October 2022
- 194 Pages
Global
From €4481EUR$5,000USD£3,844GBP
From €1792EUR$2,000USD£1,538GBP
- Report
- March 2021
- 214 Pages
Global
From €1792EUR$2,000USD£1,538GBP
- Report
- February 2021
- 80 Pages
India
From €1066EUR$1,190USD£915GBP
- Report
- January 2021
- 109 Pages
Global
€3990EUR$4,769USD£3,543GBP
- Report
- April 2020
- 182 Pages
Global
From €3585EUR$4,000USD£3,075GBP
- Report
- November 2024
- 86 Pages
Global
From €3500EUR$4,184USD£3,108GBP
- Report
- September 2025
- 85 Pages
Global
From €3500EUR$4,184USD£3,108GBP
- Report
- August 2025
- 105 Pages
Global
From €3500EUR$4,184USD£3,108GBP

The Vaccine Development market is a subset of the Vaccines industry, which focuses on the research, development, and production of vaccines. Vaccines are biological preparations that provide active acquired immunity to a particular disease. Vaccine development involves the identification of antigens, the development of a vaccine formulation, and the production of the vaccine. Vaccine development is a complex process that requires significant resources and expertise.
The Vaccine Development market is highly competitive, with many companies competing to develop and produce vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more